Cytochrome P450 Family 1 Inhibitors and Structure-Activity Relationships
暂无分享,去创建一个
[1] K. Tsai,et al. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling. , 2013, Toxicology and applied pharmacology.
[2] Ming Zhao,et al. Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1. , 2013, Journal of medicinal chemistry.
[3] G. Szklarz,et al. Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism* , 2013, The Journal of Biological Chemistry.
[4] J. Sridhar,et al. Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2. , 2013, Drug metabolism letters.
[5] Sangkyu Lee,et al. In vitro inhibitory effect of luotonin A on human CYP1A , 2012, Archives of Pharmacal Research.
[6] Charlotte M. Miller,et al. Isolation, biological activity and synthesis of the natural product ellipticine and related pyridocarbazoles , 2012 .
[7] J. J. Espinosa-Aguirre,et al. Bergamottin is a competitive inhibitor of CYP1A1 and is antimutagenic in the Ames test. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[8] A. Rimando,et al. Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1. , 2012, Bioorganic & medicinal chemistry.
[9] A. Loaiza-Pérez,et al. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment. , 2012, International journal of oncology.
[10] J. Sridhar,et al. 7-Ethynylcoumarins: selective inhibitors of human cytochrome P450s 1A1 and 1A2. , 2012, Chemical research in toxicology.
[11] F. Guengerich,et al. Contributions of human enzymes in carcinogen metabolism. , 2012, Chemical research in toxicology.
[12] J. Sridhar,et al. Inhibition of cytochrome p450 enzymes by quinones and anthraquinones. , 2012, Chemical research in toxicology.
[13] Wei-Min Zhang,et al. Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer. , 2011, Archives of medical research.
[14] J. Xu,et al. CYP1A1 Ile462Val polymorphism and susceptibility to lung cancer: a meta-analysis based on 32 studies , 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[15] Changhui Liu,et al. Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line. , 2011, Toxicology and applied pharmacology.
[16] H. Yamazaki,et al. Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. , 2010, Chemical research in toxicology.
[17] Eric F. Johnson,et al. Structural Characterization of the Complex between α-Naphthoflavone and Human Cytochrome P450 1B1* , 2010, The Journal of Biological Chemistry.
[18] F. Gonzalez,et al. Cytochrome P450 1B1 Contributes to Angiotensin II-Induced Hypertension and Associated Pathophysiology , 2010, Hypertension.
[19] T. Itoh,et al. Selective inhibition of methoxyflavonoids on human CYP1B1 activity. , 2010, Bioorganic & medicinal chemistry.
[20] S. Yamaori,et al. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes. , 2010, Biochemical pharmacology.
[21] Bo Wang,et al. Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2 , 2010, Drug metabolism reviews.
[22] Thomas K. H. Chang,et al. Inhibition of procarcinogen‐bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin , 2010, Journal of pineal research.
[23] T. Minouchi,et al. Preferential inhibition of CYP1A enzymes in hepatic microsomes by mexiletine , 1999, European Journal of Drug Metabolism and Pharmacokinetics.
[24] W. Daniel,et al. Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism — an in vitro study , 2009, Pharmacological reports : PR.
[25] Wei Duan,et al. Insights into the structure, function, and regulation of human cytochrome P450 1A2. , 2009, Current drug metabolism.
[26] Y. Chun,et al. Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbene. , 2009, Toxicology letters.
[27] B. Cravatt,et al. A suite of activity-based probes for human cytochrome P450 enzymes. , 2009, Journal of the American Chemical Society.
[28] A. D. Rodrigues,et al. Further Assessment of 17α-Ethinyl Estradiol as an Inhibitor of Different Human Cytochrome P450 Forms in Vitro , 2009, Drug Metabolism and Disposition.
[29] Hiroshi Yamazaki,et al. Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study. , 2009, Chemical research in toxicology.
[30] D. Spandidos,et al. Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention , 2009, BMC Cancer.
[31] K. Sailaja,et al. Association of CYP1A1*2 polymorphisms with breast cancer risk: a case control study. , 2009, Indian journal of medical sciences.
[32] H. Yamazaki,et al. Interaction of polycyclic aromatic hydrocarbons with human cytochrome P450 1B1 in inhibiting catalytic activity. , 2008, Chemical research in toxicology.
[33] Guangji Wang,et al. Inhibitory Effects of Seven Components of Danshen Extract on Catalytic Activity of Cytochrome P450 Enzyme in Human Liver Microsomes , 2008, Drug Metabolism and Disposition.
[34] W. Baer-Dubowska,et al. Thiomethylstilbenes as inhibitors of CYP1A1, CYP1A2 and CYP1B1 activities. , 2008, Molecular nutrition & food research.
[35] Namandjé N. Bumpus,et al. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications. , 2008, Chemical research in toxicology.
[36] P. Neuvonen,et al. Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo , 2008, European Journal of Clinical Pharmacology.
[37] R. D. Bruno,et al. Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development. , 2007, Bioorganic & medicinal chemistry.
[38] C David Stout,et al. Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2*♦ , 2007, Journal of Biological Chemistry.
[39] H. Yamazaki,et al. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors. , 2007, Chemical research in toxicology.
[40] H. Ciolino,et al. A novel synthetic analogue of a constituent of Isodon excisus inhibits transcription of CYP1A1, -1A2 and -1B1 by preventing activation of the aryl hydrocarbon receptor. , 2006, Carcinogenesis.
[41] D. Nebert,et al. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis , 2006, Nature Reviews Cancer.
[42] P. Neuvonen,et al. Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects. , 2006, British journal of clinical pharmacology.
[43] B. Patil,et al. Furocoumarins from grapefruit juice and their effect on human CYP 3A4 and CYP 1B1 isoenzymes. , 2006, Bioorganic & medicinal chemistry.
[44] Z. Dvořák,et al. Silybin and dehydrosilybin inhibit cytochrome P450 1A1 catalytic activity: A study in human keratinocytes and human hepatoma cells , 2006, Cell Biology and Toxicology.
[45] Y. Moon,et al. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.
[46] J. van Grevenynghe,et al. Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha. , 2006, Carcinogenesis.
[47] Y. Chun,et al. MODULATION OF HUMAN CYTOCHROME P450 1B1 EXPRESSION BY 2,4,3′,5′-TETRAMETHOXYSTILBENE , 2005, Drug Metabolism and Disposition.
[48] M. Stiborová,et al. Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P450. , 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[49] J. Giesy,et al. Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: Biphasic effect on CYP1A1. , 2005, Biochemical pharmacology.
[50] D. Schrenk,et al. Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes. , 2005, Biochemical pharmacology.
[51] A. Takagi,et al. Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes. , 2005, Biological & pharmaceutical bulletin.
[52] F. Guengerich,et al. Cytochrome P450 activation of arylamines and heterocyclic amines. , 2005, Annual review of pharmacology and toxicology.
[53] Y. Chun,et al. POTENT INHIBITION OF RECOMBINANT HUMAN CYTOCHROME P-450 1A1 BY PENTAMETHOXYSTILBENE , 2004, Journal of toxicology and environmental health. Part A.
[54] B. Haab,et al. Oltipraz, 3H-1,2-dithiole-3-thione, and sulforaphane induce overlapping and protective antioxidant responses in murine microglial cells. , 2004, Toxicology letters.
[55] R. Remmel,et al. Inhibition of murine cytochrome P4501A by tacrine: in vitro studies. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[56] O. Fardel,et al. Inhibition of carcinogen-bioactivating cytochrome P450 1 isoforms by amiloride derivatives. , 2004, Biochemical pharmacology.
[57] Y. Chun,et al. Potent inhibition of human cytochrome P450 1 enzymes by dimethoxyphenylvinyl thiophene , 2004, Archives of pharmacal research.
[58] Chieh-fu Chen,et al. Induction of CYP1A by a diterpene quinone tanshinone IIA isolated from a medicinal herb Salvia miltiorrhiza in C57BL/6J but not in DBA/2J mice. , 2004, Life sciences.
[59] A. D. Rodrigues,et al. Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[60] D. Lewis,et al. Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1. , 2003, Bioorganic & medicinal chemistry letters.
[61] F. Berthou,et al. Differential inhibition of human cytochrome P450 enzymes by epsilon-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages. , 2003, Life sciences.
[62] J. Xu,et al. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene , 2003, Journal of applied toxicology : JAT.
[63] F. Guengerich,et al. Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome P4501A2 , 2003, Xenobiotica; the fate of foreign compounds in biological systems.
[64] K. Monostory,et al. A study on CYP1A inhibitory action of E-2-(4'-methoxybenzylidene)-1-benzosuberone and some related chalcones and cyclic chalcone analogues. , 2003, Toxicology.
[65] T. Shimada,et al. Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of arylhydrocarbon receptor gene. , 2003, Toxicology and applied pharmacology.
[66] T. Shimada,et al. Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. , 2003, Mutation research.
[67] L. Leung,et al. Baicalein inhibits DMBA-DNA adduct formation by modulating CYP1A1 and CYP1B1 activities. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[68] Y. Chun,et al. Design, Synthesis, and Discovery of Novel trans‐Stilbene Analogues as Potent and Selective Human Cytochrome P450 1B1 Inhibitors. , 2002 .
[69] Lie-Chwen Lin,et al. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.
[70] H. Kleiner,et al. Role of cytochrome P450 1a1 and 1b1 in the metabolic activation of 7,12-dimethylbenz[a]anthracene and the effects of naturally occurring furanocoumarins on skin tumor initiation. , 2002, Chemical research in toxicology.
[71] F. Guengerich,et al. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. , 2001, Cancer research.
[72] Y. Chun,et al. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[73] P. Neuvonen,et al. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes , 2001, European Journal of Clinical Pharmacology.
[74] W. Chan,et al. Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4. , 2000, Life sciences.
[75] K. Inouye,et al. Inhibitory effects of 1,4-naphthoquinone derivatives on rat cytochrome P4501A1-dependent monooxygenase activity in recombinant yeast microsomes. , 2000, Journal of biochemistry.
[76] M. Burke,et al. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. , 2000, Toxicology.
[77] A. Guillouzo,et al. Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane. , 2000, Chemical research in toxicology.
[78] Charles V. Smith,et al. Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole. , 2000, The Journal of pharmacology and experimental therapeutics.
[79] H. Ashida,et al. Cytochrome P4501A1-Inhibitory Action of Antimutagenic Anthraquinones in Medicinal Plants and the Structure-activity Relationship , 2000, Bioscience, biotechnology, and biochemistry.
[80] F. Guengerich,et al. Plasmid-mediated expression of the UmuDC mutagenesis proteins in an Escherichia coli strain engineered for human cytochrome P450 1A2-catalyzed activation of aromatic amines. , 1999, Mutation research.
[81] Ian L. Rogers,et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. , 1999, Molecular pharmacology.
[82] F. Guengerich,et al. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. , 1999, Biochemical and biophysical research communications.
[83] H. Ciolino,et al. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. , 1999, The Biochemical journal.
[84] H. Ciolino,et al. The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor , 1999, British Journal of Cancer.
[85] H. Ciolino,et al. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. , 1998, Cancer research.
[86] S. Zhai,et al. Comparative inhibition of human cytochromes P450 1A1 and 1A2 by flavonoids. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[87] H. Yamazaki,et al. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1. , 1998, Chemical research in toxicology.
[88] D. Glaise,et al. Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture. , 1997, Carcinogenesis.
[89] M. Foroozesh,et al. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. , 1997, Chemical research in toxicology.
[90] W. Baer-Dubowska,et al. Inhibitory effects of naturally occurring coumarins on the metabolic activation of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in cultured mouse keratinocytes. , 1997, Carcinogenesis.
[91] W. Baer-Dubowska,et al. Mechanism-based inactivation of hepatic ethoxyresorufin O-dealkylation activity by naturally occurring coumarins. , 1996, Chemical research in toxicology.
[92] J. Liehr,et al. 4-Hydroxylation of estrogens as marker of human mammary tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[93] R. Vestal,et al. Relative potency of mexiletine, lidocaine, and tocainide as inhibitors of rat liver CYP1A1 activity. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[94] H. Lee,et al. Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline. , 1995, Mutation research.
[95] S. Loft,et al. Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine. , 1995, British journal of clinical pharmacology.
[96] J. DiGiovanni,et al. Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally occurring coumarins. , 1993, Chemical research in toxicology.
[97] S. Safe,et al. 6-substituted 3,4-benzocoumarins: a new structural class of inducers and inhibitors of CYP1A1-dependent activity. , 1993, Archives of biochemistry and biophysics.
[98] W. Trager,et al. Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. , 1993, Chemical research in toxicology.
[99] P. Hollenberg,et al. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide. , 1993, Chemical research in toxicology.
[100] R. Tukey,et al. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. , 1993, The Journal of pharmacology and experimental therapeutics.
[101] P. Ortiz de Montellano,et al. Determinants of protein modification versus heme alkylation: inactivation of cytochrome P450 1A1 by 1-ethynylpyrene and phenylacetylene. , 1993, Chemical research in toxicology.
[102] B. Mico,et al. 1-Aminobenzotriazole-induced destruction of hepatic and renal cytochromes P450 in male Sprague-Dawley rats. , 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.
[103] P. Ortiz de Montellano. Mechanism-based inactivation of cytochrome P450: isolation and characterization of N-alkyl heme adducts. , 1991, Methods in enzymology.
[104] A. Boobis,et al. Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. , 1990, British journal of clinical pharmacology.
[105] M. P. Arlotto,et al. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities. , 1988, Molecular pharmacology.
[106] H. Mukhtar,et al. Inhibition of epidermal xenobiotic metabolism in SENCAR mice by naturally occurring plant phenols. , 1987, Cancer research.
[107] J. Segura,et al. Accumulation of caffeine in healthy volunteers treated with furafylline. , 1987, British journal of clinical pharmacology.
[108] P. Ortiz de Montellano,et al. Branchpoint for heme alkylation and metabolite formation in the oxidation of arylacetylenes by cytochrome P-450. , 1985, The Journal of biological chemistry.
[109] P. Ortiz de Montellano,et al. Self-catalyzed inactivation of hepatic cytochrome P-450 by ethynyl substrates. , 1980, The Journal of biological chemistry.